Home

Nepochopení v rozpacích slanina teva lawsuit Prodloužit Nepříjemně Břitva

Price-fixing lawsuit deals another blow to already fragile Teva, experts  say | The Times of Israel
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel

Teva faces class-action lawsuit over US antitrust probe into price-fixing |  The Times of Israel
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel

Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes -  Pharma Technology Focus | Issue 85 | August 2019
Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes - Pharma Technology Focus | Issue 85 | August 2019

Teva & Allergan Settle WV Opioid Lawsuit For Over $160 Million | MedTruth -  Prescription Drug & Medical Device Safety | Informed Advocacy
Teva & Allergan Settle WV Opioid Lawsuit For Over $160 Million | MedTruth - Prescription Drug & Medical Device Safety | Informed Advocacy

Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN  Business
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business

Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters

Teva said to 'walk away' from settlement talks in US price-fixing lawsuit |  The Times of Israel
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel

Teva agrees to $4.35B settlement to end opioid lawsuits - Top Class Actions
Teva agrees to $4.35B settlement to end opioid lawsuits - Top Class Actions

Teva Proposes $5B Settlement for Thousands of Opioid Lawsuits | BioSpace
Teva Proposes $5B Settlement for Thousands of Opioid Lawsuits | BioSpace

Teva Stock Pressured From Antitrust Lawsuit Against Drug Makers | Barron's
Teva Stock Pressured From Antitrust Lawsuit Against Drug Makers | Barron's

Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva to pay New York $500M for role in opioid crisis - POLITICO

Teva to pay $512M to resolve Provigil-delay lawsuit
Teva to pay $512M to resolve Provigil-delay lawsuit

Drug distributors, Teva reach tentative settlement of opioids lawsuit - STAT
Drug distributors, Teva reach tentative settlement of opioids lawsuit - STAT

Teva drops lawsuit with Amicus over Creates Act dispute
Teva drops lawsuit with Amicus over Creates Act dispute

Teva Pharmaceuticals will pay $420 million in a federal case
Teva Pharmaceuticals will pay $420 million in a federal case

This Is how Teva and 19 of its Rivals Fixed U.S. Drug Prices | Ctech
This Is how Teva and 19 of its Rivals Fixed U.S. Drug Prices | Ctech

Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva settles shareholder lawsuit over generic drug | Business Insurance

Texas settles another opioid lawsuit, wins $225 million against Teva
Texas settles another opioid lawsuit, wins $225 million against Teva

California lawsuit leads to Allergan, Teva receiving $54 million fine | Fox  Business
California lawsuit leads to Allergan, Teva receiving $54 million fine | Fox Business

Attorney General Morrisey sues opioid makers Johnson & Johnson, Teva  Pharmaceuticals | WBOY.com
Attorney General Morrisey sues opioid makers Johnson & Johnson, Teva Pharmaceuticals | WBOY.com

US states accuse Teva and other drugmakers of colluding to inflate prices  over 1,000%
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%

Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says |  Ctech
Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says | Ctech

Allergan, Teva to pay $54M in San Francisco opioid lawsuit
Allergan, Teva to pay $54M in San Francisco opioid lawsuit

Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York  Times
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times

Teva to pay $54M to settle whistleblower lawsuit - Philadelphia Business  Journal
Teva to pay $54M to settle whistleblower lawsuit - Philadelphia Business Journal

Teva Pharmaceutical | PBS NewsHour
Teva Pharmaceutical | PBS NewsHour

Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top  Class Actions
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions

Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State  Prosecutors Say - The New York Times
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times

Teva ponies up $420M to settle with investors who said company hid  price-fixing scheme | Fierce Pharma
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma